150 related articles for article (PubMed ID: 18641686)
1. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7.
Ishikawa Y; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2008 Oct; 27(47):6164-74. PubMed ID: 18641686
[TBL] [Abstract][Full Text] [Related]
2. Complex regulation of cell-cycle inhibitors by Fbxw7 in mouse embryonic fibroblasts.
Masuda K; Ishikawa Y; Onoyama I; Unno M; de Alborán IM; Nakayama KI; Nakayama K
Oncogene; 2010 Mar; 29(12):1798-809. PubMed ID: 20023701
[TBL] [Abstract][Full Text] [Related]
3. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
[TBL] [Abstract][Full Text] [Related]
4. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
5. [Cell cycle regulation by F-box protein Fbxw7].
Tsunematsu R
Fukuoka Igaku Zasshi; 2009 Apr; 100(4):87-94. PubMed ID: 19562935
[No Abstract] [Full Text] [Related]
6. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis.
Onoyama I; Tsunematsu R; Matsumoto A; Kimura T; de Alborán IM; Nakayama K; Nakayama KI
J Exp Med; 2007 Nov; 204(12):2875-88. PubMed ID: 17984302
[TBL] [Abstract][Full Text] [Related]
7. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch.
Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K
Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation.
Bengoechea-Alonso MT; Ericsson J
Oncogene; 2010 Sep; 29(38):5322-8. PubMed ID: 20622901
[TBL] [Abstract][Full Text] [Related]
9. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421
[TBL] [Abstract][Full Text] [Related]
11. Expression of mouse Fbxw7 isoforms is regulated in a cell cycle- or p53-dependent manner.
Matsumoto A; Onoyama I; Nakayama KI
Biochem Biophys Res Commun; 2006 Nov; 350(1):114-9. PubMed ID: 16989775
[TBL] [Abstract][Full Text] [Related]
12. Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress.
Matsumoto A; Tateishi Y; Onoyama I; Okita Y; Nakayama K; Nakayama KI
Cancer Sci; 2011 Apr; 102(4):749-55. PubMed ID: 21205095
[TBL] [Abstract][Full Text] [Related]
13. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
14. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
15. ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.
Chan TS; Cheng LH; Hsu CC; Yang PM; Liao TY; Hsieh HY; Lin PC; HuangFu WC; Chuu CP; Tsai KK
Mol Oncol; 2024 Mar; 18(3):562-579. PubMed ID: 38279565
[TBL] [Abstract][Full Text] [Related]
16. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice.
Onoyama I; Nakayama KI
Cell Cycle; 2008 Nov; 7(21):3307-13. PubMed ID: 18948752
[TBL] [Abstract][Full Text] [Related]
17. Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells.
Duan L; Yao J; Wu X; Fan M
Biol Cell; 2006 Aug; 98(8):479-90. PubMed ID: 16608439
[TBL] [Abstract][Full Text] [Related]
18. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
[TBL] [Abstract][Full Text] [Related]
19. FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation.
Malyukova A; Brown S; Papa R; O'Brien R; Giles J; Trahair TN; Dalla Pozza L; Sutton R; Liu T; Haber M; Norris MD; Lock RB; Sangfelt O; Marshall GM
Leukemia; 2013 Apr; 27(5):1053-62. PubMed ID: 23228967
[TBL] [Abstract][Full Text] [Related]
20. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
Zhao J; Wang Y; Mu C; Xu Y; Sang J
Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
